IART
Integra Lifesciences Holdings
PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: IART
- PE Ratio
The current P/E ratio of IART cannot be calculated, as the latest EPS of -$6.46 is negative. The most recent PE ratio recorded for Integra Lifesciences Holdings was 97.13 in June 2024.
IART PE ratio history
Over the last ten years, the average PE ratio of Integra Lifesciences Holdings has been 61.71. Analyzing the last ten years, IART's PE ratio reached its highest point in the Jun 2016 quarter at 306.85, with a price of $39.89 and an EPS of $0.13. The Sep 2022 quarter saw the lowest point at 20.46, with a price of $42.36 and an EPS of $2.07.
Integra Lifesciences Holdings PE ratio by year
Maximum annual increase: 99.22% in 2023
Maximum annual decrease: -58.4% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | N/A | N/A | $12.42 | -$6.74 |
| 2024 | N/A | N/A | $22.68 | -$0.09 |
| 2023 | 51.24 | 99.22% | $43.55 | $0.85 |
| 2022 | 25.72 | -23.22% | $56.07 | $2.18 |
| 2021 | 33.5 | -18.47% | $66.99 | $2 |
| 2020 | 41.09 | -58.4% | $64.92 | $1.58 |
| 2019 | 98.78 | 59.89% | $58.28 | $0.59 |
| 2018 | 61.78 | 8.42% | $45.1 | $0.73 |
| 2017 | 56.98 | 32.82% | $47.86 | $0.84 |
| 2016 | 42.9 | N/A | $42.9 | $1 |
| 2015 | N/A | N/A | $33.89 | -$0.05 |
| 2014 | 52.14 | N/A | $27.12 | $0.52 |
| 2013 | N/A | N/A | $23.86 | -$0.37 |
| 2012 | 26.69 | -15.16% | $19.49 | $0.73 |
| 2011 | 31.46 | 46.33% | $15.42 | $0.49 |
Integra Lifesciences Holdings PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | N/A | N/A | $9.42 | -$6.46 |
| Dec 2025 | N/A | N/A | $12.42 | -$6.74 |
| Sep 2025 | N/A | N/A | $14.33 | -$6.46 |
| Jun 2025 | N/A | N/A | $12.27 | -$6.53 |
| Mar 2025 | N/A | N/A | $21.99 | -$0.38 |
| Dec 2024 | N/A | N/A | $22.68 | -$0.09 |
| Sep 2024 | N/A | N/A | $18.17 | -$0.08 |
| Jun 2024 | 97.13 | 39.74% | $29.14 | $0.3 |
| Mar 2024 | 69.51 | 35.66% | $35.45 | $0.51 |
| Dec 2023 | 51.24 | 65.02% | $43.55 | $0.85 |
| Sep 2023 | 31.05 | 20.02% | $38.19 | $1.23 |
| Jun 2023 | 25.87 | -6.27% | $41.13 | $1.59 |
| Mar 2023 | 27.6 | 7.31% | $57.41 | $2.08 |
| Dec 2022 | 25.72 | 25.71% | $56.07 | $2.18 |
| Sep 2022 | 20.46 | -25.03% | $42.36 | $2.07 |
IART Price vs fair value
IART average PE ratio chart
What this chart measures
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
Percentile logic
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
Regime map
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
How to read each part
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Important metric definitions
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
How to use it well
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
PE comparison
IART PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| CNMD CONMED Corp | 19.01 | $1.01B |
| MDT Medtronic plc | 21.42 | $102.83B |
| JNJ Johnson & Johnson | 27.02 | $567.77B |
| CAH Cardinal Health Inc | 34.59 | $53.22B |
| SYK Stryker Corp | 35.3 | $118.27B |
| TFX Teleflex Inc | N/A | $5.48B |
| XRAY DENTSPLY SIRONA Inc | N/A | $2.04B |
| IART Integra Lifesciences Holdings Corp | N/A | $1.39B |
Frequently asked questions
What is Integra Lifesciences Holdings's PE ratio?
The current price to earnings ratio of IART cannot be determined, as its EPS of -$6.46 is negative.
What is the 3-year average PE ratio for Integra Lifesciences Holdings (IART)?
Over the last 3 years, the average PE ratio for IART stock is 54.96.
What is the 5-year average PE ratio for Integra Lifesciences Holdings (IART)?
Over the last 5 years, the average PE ratio for IART stock is 38.4.
What is the highest PE ratio for IART?
Over the last ten years, the quarterly PE ratio reached its highest level at 306.85 in the Jun 2016 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.